New Partner

New partnerEric Reiter Teams (BIOS, INRA – Nouzilly) working on nanobodies -


The axis developed a new partnership with the team of E. Reiter (Bios - INRA - Nouzilly ) on targeting SDF1 / CXCR4 axis by anti-CXCR4 nanobodies in different models of tumor niches.


Drawing on the expertise of this new partnership, the axis hopes to developed new innovative approaches targeting the cancer niche.


This partnership is marked by the deposit of project at “CGO structuring call offer 2015”.

Go back